Logotype for TriMas Corporation

TriMas (TRS) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for TriMas Corporation

Q2 2024 earnings summary

2 Feb, 2026

Executive summary

  • Q2 2024 net sales increased 3.1% year-over-year to $240.5 million, driven by strong growth in Packaging (+12.5%) and Aerospace (+30%), offset by a sharp decline in Specialty Products due to demand softness and overstocking.

  • Adjusted operating profit and EPS declined year-over-year, mainly due to Specialty Products weakness and the absence of prior-year favorable items.

  • Operational improvements and strategic investments in Packaging and Aerospace are yielding positive results, with both segments expected to maintain or exceed internal targets.

  • Specialty Products segment underperformed expectations, prompting cost reductions, restructuring, and a planned exit from the oil and gas market.

  • Share repurchases reduced net shares outstanding by 1.3% year-to-date, with $70.1M remaining under repurchase authorization.

Financial highlights

  • Q2 2024 net sales: $240.5M (+3.1% YoY); adjusted EBITDA: $36.6M (15.2% margin), down from $45.5M (19.5%) prior year.

  • Adjusted EPS: $0.43 (down from $0.56); net income: $10.9M (flat YoY); adjusted net income: $17.5M (down from $23.4M).

  • Q2 2024 operating profit: $17.9M (7.4% margin), down from $20.1M (8.6%) in Q2 2023.

  • Free cash flow: $11.4M, in line with last year.

  • Net leverage ratio: 2.6x–2.7x; net debt: $392.4M as of June 30, 2024.

Outlook and guidance

  • Full-year 2024 sales growth expected at 4%–6%, revised down from earlier guidance.

  • Full-year adjusted EPS guidance lowered to $1.70–$1.90 from $1.95–$2.15, reflecting Specialty Products weakness and higher interest expense.

  • Packaging sales growth guidance raised to 9%–10%, with adjusted EBITDA margin 21%–23%.

  • Aerospace sales growth guidance increased to 18%–22%, with adjusted EBITDA margin 18%–19%.

  • Specialty Products sales expected to decline 25%–30% for the year, with adjusted EBITDA margin guidance reduced to 10%–14%.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more